Gene Symbol | Gene ID | Gene Info |
---|---|---|
HESX1
|
ENSG00000163666.4 | HESX homeobox 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr3_57258884_57259035 | HESX1 | 1590 | 0.344356 | 0.86 | 3.2e-03 | Click! |
chr3_57230333_57230484 | HESX1 | 3558 | 0.225511 | 0.62 | 7.2e-02 | Click! |
chr3_57233953_57234104 | HESX1 | 45 | 0.975388 | 0.56 | 1.2e-01 | Click! |
chr3_57258671_57258822 | HESX1 | 1803 | 0.314127 | 0.47 | 2.0e-01 | Click! |
chr3_57260204_57260355 | HESX1 | 270 | 0.877603 | 0.35 | 3.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr11_2933384_2933685 | 0.65 |
SLC22A18AS |
solute carrier family 22 (organic cation transporter), member 18 antisense |
8564 |
0.12 |
chr2_232229722_232230070 | 0.44 |
ENSG00000263641 |
. |
2477 |
0.26 |
chr18_9016875_9017135 | 0.41 |
NDUFV2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
85623 |
0.08 |
chr2_87901691_87901863 | 0.39 |
ENSG00000265507 |
. |
27497 |
0.24 |
chr5_145356260_145356548 | 0.39 |
SH3RF2 |
SH3 domain containing ring finger 2 |
38964 |
0.18 |
chr16_70780334_70780534 | 0.38 |
RP11-394B2.6 |
|
526 |
0.69 |
chr7_20447658_20447906 | 0.37 |
ENSG00000200753 |
. |
30828 |
0.2 |
chrX_69697630_69697850 | 0.35 |
DLG3-AS1 |
DLG3 antisense RNA 1 |
21896 |
0.14 |
chr8_122360906_122361134 | 0.33 |
ENSG00000221644 |
. |
161888 |
0.04 |
chr18_21464195_21464346 | 0.32 |
LAMA3 |
laminin, alpha 3 |
467 |
0.84 |
chr7_100322881_100323094 | 0.32 |
EPO |
erythropoietin |
4564 |
0.12 |
chr1_46649466_46650029 | 0.31 |
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
7587 |
0.12 |
chr1_22231017_22231447 | 0.31 |
HSPG2 |
heparan sulfate proteoglycan 2 |
8429 |
0.18 |
chr8_30333332_30333499 | 0.31 |
RBPMS |
RNA binding protein with multiple splicing |
33282 |
0.2 |
chr2_9374494_9374810 | 0.30 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
27758 |
0.24 |
chr2_19850164_19850315 | 0.30 |
TTC32 |
tetratricopeptide repeat domain 32 |
251163 |
0.02 |
chr1_183776609_183776992 | 0.29 |
RGL1 |
ral guanine nucleotide dissociation stimulator-like 1 |
2510 |
0.36 |
chr3_149291004_149291431 | 0.29 |
WWTR1 |
WW domain containing transcription regulator 1 |
2822 |
0.29 |
chr11_13157469_13157634 | 0.28 |
ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
140648 |
0.04 |
chr3_71591322_71591805 | 0.28 |
ENSG00000221264 |
. |
323 |
0.83 |
chr18_53156534_53156869 | 0.28 |
RP11-619L19.2 |
|
2705 |
0.26 |
chr10_14823935_14824305 | 0.28 |
FAM107B |
family with sequence similarity 107, member B |
7224 |
0.22 |
chr4_124477064_124477262 | 0.28 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
156040 |
0.04 |
chr7_75920639_75920802 | 0.28 |
ENSG00000263569 |
. |
2612 |
0.23 |
chr6_153450838_153450989 | 0.27 |
RGS17 |
regulator of G-protein signaling 17 |
1471 |
0.45 |
chr8_49332411_49332756 | 0.27 |
ENSG00000252710 |
. |
111993 |
0.07 |
chr9_84646672_84646823 | 0.27 |
SPATA31D1 |
SPATA31 subfamily D, member 1 |
43060 |
0.17 |
chr16_58058882_58059051 | 0.27 |
MMP15 |
matrix metallopeptidase 15 (membrane-inserted) |
504 |
0.72 |
chr12_25074971_25075143 | 0.27 |
BCAT1 |
branched chain amino-acid transaminase 1, cytosolic |
19048 |
0.16 |
chr7_12768879_12769087 | 0.27 |
ENSG00000199470 |
. |
28469 |
0.2 |
chr7_129995708_129995942 | 0.26 |
CPA5 |
carboxypeptidase A5 |
7457 |
0.14 |
chr8_141954682_141954850 | 0.26 |
ENSG00000252864 |
. |
4105 |
0.27 |
chr11_57528771_57528928 | 0.26 |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
385 |
0.8 |
chr3_71592415_71592862 | 0.26 |
FOXP1 |
forkhead box P1 |
70 |
0.96 |
chr19_588658_588919 | 0.26 |
HCN2 |
hyperpolarization activated cyclic nucleotide-gated potassium channel 2 |
1105 |
0.3 |
chr2_101728983_101729400 | 0.26 |
ENSG00000265860 |
. |
19160 |
0.19 |
chr12_46825311_46825703 | 0.26 |
SLC38A2 |
solute carrier family 38, member 2 |
58857 |
0.14 |
chr22_27884822_27884973 | 0.26 |
RP11-375H17.1 |
|
227571 |
0.02 |
chr22_38139115_38139288 | 0.25 |
TRIOBP |
TRIO and F-actin binding protein |
3034 |
0.16 |
chr11_13162108_13162259 | 0.25 |
ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
136016 |
0.05 |
chr2_122242346_122242497 | 0.25 |
CLASP1 |
cytoplasmic linker associated protein 1 |
5483 |
0.24 |
chr8_21989039_21989190 | 0.25 |
HR |
hair growth associated |
267 |
0.85 |
chr21_39850220_39850518 | 0.25 |
ERG |
v-ets avian erythroblastosis virus E26 oncogene homolog |
19976 |
0.28 |
chr1_16466515_16466919 | 0.25 |
RP11-276H7.2 |
|
14989 |
0.11 |
chr3_196750502_196750801 | 0.25 |
MFI2 |
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
6007 |
0.19 |
chr3_42085911_42086330 | 0.25 |
TRAK1 |
trafficking protein, kinesin binding 1 |
46442 |
0.16 |
chr3_18140205_18140557 | 0.24 |
RP11-158G18.1 |
|
310746 |
0.01 |
chr5_73611648_73611799 | 0.24 |
ENSG00000244326 |
. |
2088 |
0.42 |
chr1_162359766_162359944 | 0.24 |
C1orf226 |
chromosome 1 open reading frame 226 |
8335 |
0.12 |
chr16_53822990_53823141 | 0.24 |
FTO |
fat mass and obesity associated |
84971 |
0.09 |
chr19_18364497_18364688 | 0.24 |
PDE4C |
phosphodiesterase 4C, cAMP-specific |
1637 |
0.23 |
chr2_47313454_47313781 | 0.23 |
AC073283.7 |
|
18656 |
0.18 |
chr8_69244650_69244960 | 0.23 |
RP11-664D7.4 |
HCG1787533; Uncharacterized protein |
1079 |
0.45 |
chr14_31559795_31560006 | 0.23 |
AP4S1 |
adaptor-related protein complex 4, sigma 1 subunit |
24398 |
0.15 |
chr18_46775674_46776034 | 0.23 |
DYM |
dymeclin |
8924 |
0.23 |
chr15_90233678_90233930 | 0.23 |
PEX11A |
peroxisomal biogenesis factor 11 alpha |
89 |
0.68 |
chr7_41745636_41745841 | 0.23 |
AC005027.3 |
|
805 |
0.63 |
chr19_18491287_18491451 | 0.23 |
GDF15 |
growth differentiation factor 15 |
1611 |
0.2 |
chr11_75735939_75736309 | 0.23 |
UVRAG |
UV radiation resistance associated |
41644 |
0.15 |
chr3_9006994_9007145 | 0.23 |
RAD18 |
RAD18 homolog (S. cerevisiae) |
1612 |
0.41 |
chr8_78478320_78478688 | 0.23 |
ENSG00000222334 |
. |
279452 |
0.02 |
chr22_31479008_31479415 | 0.23 |
RP3-412A9.16 |
|
340 |
0.68 |
chr14_69421781_69422763 | 0.23 |
ACTN1 |
actinin, alpha 1 |
8007 |
0.23 |
chr14_73713964_73714115 | 0.23 |
ENSG00000252839 |
. |
451 |
0.7 |
chr9_37998944_37999499 | 0.23 |
ENSG00000251745 |
. |
62456 |
0.11 |
chr17_75361709_75362043 | 0.23 |
SEPT9 |
septin 9 |
7396 |
0.18 |
chr3_23918662_23918822 | 0.23 |
RPL15 |
ribosomal protein L15 |
39294 |
0.13 |
chr11_1913396_1913650 | 0.23 |
C11orf89 |
chromosome 11 open reading frame 89 |
1439 |
0.25 |
chr5_177676308_177676676 | 0.23 |
PHYKPL |
5-phosphohydroxy-L-lysine phospho-lyase |
16706 |
0.19 |
chr22_46404101_46404436 | 0.23 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
31259 |
0.1 |
chr3_49384271_49384510 | 0.22 |
USP4 |
ubiquitin specific peptidase 4 (proto-oncogene) |
6886 |
0.11 |
chr2_9427415_9427711 | 0.22 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
80669 |
0.1 |
chr7_47446099_47446250 | 0.22 |
TNS3 |
tensin 3 |
46655 |
0.2 |
chr3_43810178_43810362 | 0.22 |
ABHD5 |
abhydrolase domain containing 5 |
57071 |
0.15 |
chr2_26981757_26981908 | 0.22 |
SLC35F6 |
solute carrier family 35, member F6 |
5324 |
0.2 |
chr1_26217257_26217408 | 0.22 |
ENSG00000207302 |
. |
13345 |
0.08 |
chr5_139601602_139601854 | 0.22 |
CTB-131B5.2 |
|
21980 |
0.13 |
chr18_32229938_32230237 | 0.22 |
DTNA |
dystrobrevin, alpha |
29414 |
0.24 |
chr15_82469698_82469948 | 0.22 |
ENSG00000212170 |
. |
3097 |
0.28 |
chr12_6643029_6643180 | 0.22 |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
11 |
0.85 |
chr1_211433518_211433965 | 0.22 |
RCOR3 |
REST corepressor 3 |
424 |
0.87 |
chr10_98976859_98977010 | 0.22 |
SLIT1 |
slit homolog 1 (Drosophila) |
31257 |
0.14 |
chr2_151477648_151477907 | 0.21 |
RND3 |
Rho family GTPase 3 |
82252 |
0.12 |
chr4_129768306_129768457 | 0.21 |
JADE1 |
jade family PHD finger 1 |
15793 |
0.28 |
chr15_40536086_40536237 | 0.21 |
PAK6 |
p21 protein (Cdc42/Rac)-activated kinase 6 |
3315 |
0.14 |
chr12_46465588_46465739 | 0.21 |
SCAF11 |
SR-related CTD-associated factor 11 |
79760 |
0.11 |
chr6_163777027_163777374 | 0.21 |
QKI |
QKI, KH domain containing, RNA binding |
58475 |
0.16 |
chr16_2198362_2198540 | 0.21 |
RAB26 |
RAB26, member RAS oncogene family |
174 |
0.83 |
chr1_205920578_205920729 | 0.21 |
SLC26A9 |
solute carrier family 26 (anion exchanger), member 9 |
8065 |
0.21 |
chr7_105709201_105709352 | 0.21 |
SYPL1 |
synaptophysin-like 1 |
29032 |
0.21 |
chr17_38178972_38179123 | 0.21 |
MED24 |
mediator complex subunit 24 |
366 |
0.78 |
chr1_202251446_202251597 | 0.21 |
ENSG00000239046 |
. |
50729 |
0.1 |
chr20_39861758_39862098 | 0.21 |
ZHX3 |
zinc fingers and homeoboxes 3 |
29247 |
0.18 |
chr8_97803430_97803993 | 0.21 |
CPQ |
carboxypeptidase Q |
30243 |
0.25 |
chr9_111826033_111826184 | 0.21 |
ENSG00000207698 |
. |
17530 |
0.14 |
chr17_46560355_46560520 | 0.21 |
ENSG00000206805 |
. |
3978 |
0.15 |
chr1_174758949_174759102 | 0.21 |
RABGAP1L |
RAB GTPase activating protein 1-like |
10045 |
0.28 |
chr1_31574214_31574369 | 0.21 |
PUM1 |
pumilio RNA-binding family member 1 |
35453 |
0.17 |
chr3_37988212_37988363 | 0.21 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
17783 |
0.15 |
chr4_157884715_157884866 | 0.21 |
PDGFC |
platelet derived growth factor C |
7265 |
0.23 |
chr9_116383050_116383201 | 0.21 |
RGS3 |
regulator of G-protein signaling 3 |
27359 |
0.19 |
chr19_12902017_12902168 | 0.21 |
JUNB |
jun B proto-oncogene |
218 |
0.81 |
chr11_57123702_57124132 | 0.21 |
ENSG00000266018 |
. |
3279 |
0.12 |
chr3_117716057_117716400 | 0.20 |
LSAMP |
limbic system-associated membrane protein |
133 |
0.98 |
chr3_66499792_66500068 | 0.20 |
LRIG1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
51426 |
0.17 |
chr22_19161927_19162579 | 0.20 |
AC004463.6 |
|
3345 |
0.15 |
chr17_62196110_62196316 | 0.20 |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
11272 |
0.16 |
chr22_46402793_46403252 | 0.20 |
WNT7B |
wingless-type MMTV integration site family, member 7B |
30013 |
0.1 |
chr5_176965550_176965701 | 0.20 |
FAM193B |
family with sequence similarity 193, member B |
727 |
0.52 |
chr14_105147633_105147901 | 0.20 |
ENSG00000265291 |
. |
3681 |
0.16 |
chr15_101986013_101986263 | 0.20 |
PCSK6 |
proprotein convertase subtilisin/kexin type 6 |
2270 |
0.39 |
chr3_42077345_42077717 | 0.20 |
TRAK1 |
trafficking protein, kinesin binding 1 |
55031 |
0.14 |
chr1_173159483_173159962 | 0.20 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
14975 |
0.26 |
chr3_100618907_100619221 | 0.20 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
14244 |
0.25 |
chr14_58748062_58749029 | 0.20 |
RP11-349A22.5 |
|
5196 |
0.12 |
chr1_206713627_206713778 | 0.20 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
16791 |
0.15 |
chr2_46370239_46370448 | 0.20 |
AC017006.3 |
|
24774 |
0.22 |
chr15_85457860_85458027 | 0.20 |
ENSG00000207037 |
. |
23810 |
0.13 |
chr2_1597634_1597785 | 0.20 |
AC144450.1 |
|
26176 |
0.23 |
chr9_127541109_127541454 | 0.20 |
OLFML2A |
olfactomedin-like 2A |
1731 |
0.28 |
chr1_33925705_33926114 | 0.20 |
ZSCAN20 |
zinc finger and SCAN domain containing 20 |
12337 |
0.17 |
chr10_72424330_72424481 | 0.20 |
ADAMTS14 |
ADAM metallopeptidase with thrombospondin type 1 motif, 14 |
8154 |
0.25 |
chr1_214618510_214618915 | 0.20 |
PTPN14 |
protein tyrosine phosphatase, non-receptor type 14 |
19434 |
0.26 |
chr12_71833733_71833884 | 0.20 |
LGR5 |
leucine-rich repeat containing G protein-coupled receptor 5 |
5 |
0.98 |
chr22_42232265_42232534 | 0.20 |
RP5-821D11.7 |
|
1730 |
0.24 |
chr12_121551768_121551919 | 0.20 |
ENSG00000201945 |
. |
6997 |
0.18 |
chr8_105599662_105599940 | 0.20 |
LRP12 |
low density lipoprotein receptor-related protein 12 |
1433 |
0.43 |
chr4_157700524_157700675 | 0.20 |
RP11-154F14.2 |
|
61912 |
0.13 |
chr10_101469768_101470055 | 0.20 |
COX15 |
cytochrome c oxidase assembly homolog 15 (yeast) |
21946 |
0.14 |
chr3_131262586_131262737 | 0.20 |
RP11-517B11.4 |
|
25986 |
0.18 |
chr4_84607156_84607307 | 0.20 |
ENSG00000201633 |
. |
49788 |
0.18 |
chr8_28557924_28558130 | 0.20 |
EXTL3-AS1 |
EXTL3 antisense RNA 1 |
20 |
0.95 |
chr10_21799067_21799308 | 0.20 |
SKIDA1 |
SKI/DACH domain containing 1 |
7661 |
0.13 |
chr1_27855366_27855678 | 0.19 |
RP1-159A19.4 |
|
3206 |
0.23 |
chr3_47203435_47204414 | 0.19 |
SETD2 |
SET domain containing 2 |
1142 |
0.44 |
chr5_56467993_56468852 | 0.19 |
GPBP1 |
GC-rich promoter binding protein 1 |
1353 |
0.47 |
chr14_71878577_71878728 | 0.19 |
ENSG00000207444 |
. |
13598 |
0.23 |
chr1_152022964_152023546 | 0.19 |
S100A11 |
S100 calcium binding protein A11 |
13744 |
0.14 |
chr19_40917025_40917176 | 0.19 |
PRX |
periaxin |
2171 |
0.17 |
chr17_78801110_78801319 | 0.19 |
RP11-28G8.1 |
|
21782 |
0.2 |
chr10_102124571_102124984 | 0.19 |
SCD |
stearoyl-CoA desaturase (delta-9-desaturase) |
17896 |
0.13 |
chr10_95236634_95236862 | 0.19 |
MYOF |
myoferlin |
5203 |
0.21 |
chr14_35838262_35838413 | 0.19 |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
35009 |
0.18 |
chr1_8931641_8932436 | 0.19 |
ENO1-IT1 |
ENO1 intronic transcript 1 (non-protein coding) |
6028 |
0.14 |
chr5_14186957_14187108 | 0.19 |
TRIO |
trio Rho guanine nucleotide exchange factor |
3125 |
0.41 |
chr16_85406554_85407024 | 0.19 |
RP11-680G10.1 |
Uncharacterized protein |
15720 |
0.23 |
chr21_44877468_44877619 | 0.19 |
SIK1 |
salt-inducible kinase 1 |
30535 |
0.22 |
chr9_131675686_131675837 | 0.19 |
PHYHD1 |
phytanoyl-CoA dioxygenase domain containing 1 |
7413 |
0.12 |
chr1_974711_974945 | 0.19 |
AGRN |
agrin |
11108 |
0.08 |
chr8_96235521_96235672 | 0.19 |
C8orf37 |
chromosome 8 open reading frame 37 |
45833 |
0.16 |
chr22_20886096_20886271 | 0.19 |
MED15 |
mediator complex subunit 15 |
7621 |
0.12 |
chr1_207198601_207198841 | 0.19 |
C1orf116 |
chromosome 1 open reading frame 116 |
7371 |
0.14 |
chr2_17776047_17776198 | 0.19 |
VSNL1 |
visinin-like 1 |
53695 |
0.15 |
chr2_99525996_99526176 | 0.19 |
KIAA1211L |
KIAA1211-like |
1102 |
0.61 |
chr6_16681395_16681795 | 0.19 |
RP1-151F17.1 |
|
79774 |
0.1 |
chr2_224680140_224680291 | 0.19 |
AP1S3 |
adaptor-related protein complex 1, sigma 3 subunit |
21986 |
0.25 |
chr2_36566234_36566385 | 0.19 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
16760 |
0.29 |
chr9_131312108_131312259 | 0.19 |
RP11-216B9.6 |
|
2506 |
0.16 |
chr11_72182622_72182831 | 0.19 |
CLPB |
ClpB caseinolytic peptidase B homolog (E. coli) |
37034 |
0.13 |
chr9_137443475_137443828 | 0.19 |
COL5A1 |
collagen, type V, alpha 1 |
89969 |
0.08 |
chr1_55316145_55316296 | 0.19 |
DHCR24 |
24-dehydrocholesterol reductase |
3619 |
0.18 |
chr12_96629440_96629591 | 0.19 |
RP11-394J1.2 |
|
11764 |
0.2 |
chr12_26790030_26790181 | 0.18 |
RP11-666F17.1 |
|
13803 |
0.28 |
chr2_61176487_61176638 | 0.18 |
ENSG00000201076 |
. |
38124 |
0.13 |
chr17_48125226_48125421 | 0.18 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
8016 |
0.14 |
chr3_72368118_72368657 | 0.18 |
ENSG00000212070 |
. |
56808 |
0.16 |
chr2_69034764_69034964 | 0.18 |
ARHGAP25 |
Rho GTPase activating protein 25 |
501 |
0.82 |
chr5_1564026_1564340 | 0.18 |
SDHAP3 |
succinate dehydrogenase complex, subunit A, flavoprotein pseudogene 3 |
15512 |
0.2 |
chr11_67776489_67776640 | 0.18 |
ALDH3B1 |
aldehyde dehydrogenase 3 family, member B1 |
516 |
0.66 |
chr6_18276971_18277268 | 0.18 |
ENSG00000199715 |
. |
3622 |
0.22 |
chr15_45475820_45475971 | 0.18 |
SHF |
Src homology 2 domain containing F |
2490 |
0.16 |
chr1_1308946_1309097 | 0.18 |
AURKAIP1 |
aurora kinase A interacting protein 1 |
1516 |
0.17 |
chr19_4376907_4377058 | 0.18 |
SH3GL1 |
SH3-domain GRB2-like 1 |
3307 |
0.1 |
chr15_90755314_90755522 | 0.18 |
SEMA4B |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
9564 |
0.12 |
chr20_4022392_4022773 | 0.18 |
RNF24 |
ring finger protein 24 |
26353 |
0.17 |
chr2_114734263_114734750 | 0.18 |
ENSG00000215984 |
. |
13167 |
0.22 |
chr3_172025154_172025305 | 0.18 |
AC092964.2 |
Uncharacterized protein |
5543 |
0.23 |
chr2_69198318_69198469 | 0.18 |
GKN1 |
gastrokine 1 |
3312 |
0.24 |
chr6_139690937_139691976 | 0.18 |
CITED2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
3894 |
0.32 |
chr2_106026554_106026715 | 0.18 |
FHL2 |
four and a half LIM domains 2 |
10510 |
0.21 |
chr11_74494315_74495146 | 0.18 |
ENSG00000264095 |
. |
30101 |
0.12 |
chr8_59746742_59746914 | 0.18 |
ENSG00000201231 |
. |
19717 |
0.27 |
chr10_48180819_48181165 | 0.18 |
AGAP9 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 |
8620 |
0.19 |
chr10_106110579_106111072 | 0.18 |
CCDC147-AS1 |
CCDC147 antisense RNA 1 (head to head) |
2508 |
0.19 |
chr3_127468992_127469231 | 0.18 |
MGLL |
monoglyceride lipase |
13911 |
0.23 |
chr13_49877691_49877842 | 0.18 |
CAB39L |
calcium binding protein 39-like |
47497 |
0.14 |
chr11_112193182_112193453 | 0.18 |
ENSG00000206772 |
. |
30068 |
0.14 |
chr5_6506361_6506512 | 0.18 |
UBE2QL1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
57700 |
0.15 |
chr5_9545281_9545432 | 0.18 |
SEMA5A |
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
831 |
0.6 |
chr2_237640623_237640774 | 0.18 |
ACKR3 |
atypical chemokine receptor 3 |
162414 |
0.04 |
chr10_93869895_93870086 | 0.18 |
ENSG00000252993 |
. |
33991 |
0.16 |
chr14_85999126_85999357 | 0.18 |
FLRT2 |
fibronectin leucine rich transmembrane protein 2 |
2669 |
0.33 |
chr11_10696838_10697077 | 0.18 |
MRVI1 |
murine retrovirus integration site 1 homolog |
18104 |
0.17 |
chr6_44537708_44537867 | 0.18 |
ENSG00000266619 |
. |
134409 |
0.05 |
chr22_32025367_32025527 | 0.18 |
PISD |
phosphatidylserine decarboxylase |
479 |
0.82 |
chr7_94286288_94286555 | 0.18 |
PEG10 |
paternally expressed 10 |
739 |
0.49 |
chr5_14168529_14168851 | 0.18 |
TRIO |
trio Rho guanine nucleotide exchange factor |
15217 |
0.3 |
chr7_50782493_50782644 | 0.18 |
GRB10 |
growth factor receptor-bound protein 10 |
3964 |
0.34 |
chr17_49134950_49135182 | 0.18 |
SPAG9 |
sperm associated antigen 9 |
10827 |
0.17 |
chr1_220473543_220473841 | 0.18 |
RAB3GAP2 |
RAB3 GTPase activating protein subunit 2 (non-catalytic) |
27896 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.3 | GO:1900116 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.1 | 0.2 | GO:0044413 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.1 | 0.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.1 | 0.1 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.1 | 0.2 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.1 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.1 | 0.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.1 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.1 | 0.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.2 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.1 | GO:0060433 | bronchus development(GO:0060433) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.0 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.0 | 0.1 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.0 | 0.1 | GO:0017014 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.0 | 0.1 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.0 | 0.0 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.1 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.3 | GO:0048755 | branching morphogenesis of a nerve(GO:0048755) |
0.0 | 0.0 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.0 | 0.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) cerebral cortex GABAergic interneuron migration(GO:0021853) cerebral cortex GABAergic interneuron development(GO:0021894) interneuron migration(GO:1904936) |
0.0 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.0 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.1 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.0 | 0.1 | GO:1902170 | cellular response to nitric oxide(GO:0071732) cellular response to reactive nitrogen species(GO:1902170) |
0.0 | 0.2 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.0 | 0.1 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.3 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.1 | GO:1904181 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
0.0 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
0.0 | 0.2 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.1 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.0 | 0.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.2 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.0 | 0.1 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.0 | 0.1 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
0.0 | 0.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.0 | 0.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:1903299 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
0.0 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.0 | 0.1 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.0 | GO:0003308 | regulation of Wnt signaling pathway involved in heart development(GO:0003307) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.0 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0072239 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
0.0 | 0.1 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.0 | 0.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.0 | 0.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.0 | 0.0 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) regulation of aldosterone metabolic process(GO:0032344) regulation of aldosterone biosynthetic process(GO:0032347) |
0.0 | 0.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.1 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.0 | 0.1 | GO:0090049 | regulation of cell migration involved in sprouting angiogenesis(GO:0090049) regulation of sprouting angiogenesis(GO:1903670) |
0.0 | 0.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.0 | 0.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.0 | 0.1 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.0 | 0.1 | GO:0008614 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.0 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.1 | GO:0008218 | bioluminescence(GO:0008218) |
0.0 | 0.1 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.1 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.0 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.0 | 0.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.3 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.0 | 0.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.0 | 0.1 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.0 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.0 | 0.0 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.0 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.1 | GO:0044319 | wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.2 | GO:0071453 | cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
0.0 | 0.0 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.0 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.0 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 0.1 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.1 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.0 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.0 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.0 | 0.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.0 | 0.2 | GO:0007431 | salivary gland development(GO:0007431) |
0.0 | 0.3 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.0 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.1 | GO:0010587 | miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
0.0 | 0.0 | GO:0055022 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
0.0 | 0.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.2 | GO:0035272 | exocrine system development(GO:0035272) |
0.0 | 0.1 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.0 | 0.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.3 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.2 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.0 | 0.0 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.2 | GO:0019098 | mating behavior(GO:0007617) reproductive behavior(GO:0019098) multi-organism reproductive behavior(GO:0044705) |
0.0 | 0.1 | GO:0009415 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:1901722 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) cell proliferation involved in metanephros development(GO:0072203) regulation of cell proliferation involved in kidney development(GO:1901722) |
0.0 | 0.1 | GO:0061001 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.0 | 0.1 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.0 | 0.0 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.0 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
0.0 | 0.2 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.0 | GO:0046475 | phosphatidylcholine catabolic process(GO:0034638) glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0048844 | artery morphogenesis(GO:0048844) |
0.0 | 0.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.2 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.0 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.0 | 0.1 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.0 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.1 | GO:0010894 | negative regulation of steroid biosynthetic process(GO:0010894) |
0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.0 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.0 | 0.0 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0021604 | facial nerve development(GO:0021561) rhombomere 4 development(GO:0021570) cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.0 | 0.0 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.1 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.1 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.1 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.0 | 0.0 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.1 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.2 | GO:0006693 | prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.0 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.0 | 0.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:2000300 | regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.1 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.1 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.1 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.0 | GO:0060841 | venous blood vessel development(GO:0060841) |
0.0 | 0.0 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 0.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.1 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.0 | 0.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.3 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.0 | 0.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.0 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.0 | 0.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.0 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.0 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.0 | 0.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.0 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
0.0 | 0.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.0 | 0.2 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.0 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) regulation of steroid hormone biosynthetic process(GO:0090030) |
0.0 | 0.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.5 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.0 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.0 | 0.0 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0098876 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0045217 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.1 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.0 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.2 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.1 | GO:0010092 | specification of organ identity(GO:0010092) |
0.0 | 0.1 | GO:0007044 | cell-substrate junction assembly(GO:0007044) |
0.0 | 0.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.0 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.0 | GO:2001235 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.0 | 0.0 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.1 | GO:0090398 | cellular senescence(GO:0090398) |
0.0 | 0.1 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.0 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.0 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.0 | GO:0016266 | O-glycan processing(GO:0016266) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.0 | 0.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.2 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.0 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.0 | 0.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.1 | GO:0043256 | laminin complex(GO:0043256) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 0.1 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.0 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.0 | GO:0043205 | fibril(GO:0043205) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.0 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.0 | 0.0 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.4 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.0 | 0.5 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.0 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.0 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.6 | GO:0030426 | growth cone(GO:0030426) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.4 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.1 | 0.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.3 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.2 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.1 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
0.1 | 0.3 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.0 | 0.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.0 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.2 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.0 | 0.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.0 | 0.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.0 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.2 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.0 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 0.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.1 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 0.2 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.0 | 0.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.0 | 0.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.0 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.0 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.0 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.0 | 0.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.4 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 0.0 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.0 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.0 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.0 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.0 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.1 | GO:0044620 | ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process(GO:0000036) ACP phosphopantetheine attachment site binding(GO:0044620) prosthetic group binding(GO:0051192) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 0.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 0.3 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.0 | 0.0 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.0 | 0.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.0 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.1 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.0 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.2 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.4 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 1.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.0 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.0 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.0 | 0.3 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.0 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.0 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 1.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |